Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Future Medicinal Chemistry|March 24, 2011
Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virusTanya Parkinson, David C PrydeThe Journal of Antimicrobial Chemotherapy|January 20, 2012
Antiviral applications of Toll-like receptor agonistsNigel J Horscroft, David C Pryde, Helen BrightExpert Opinion on Drug Discovery|March 16, 2013
Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymeraseTod P Holler, Tanya Parkinson, David C PrydeChemical Science|April 29, 2017
Site-selective Suzuki-Miyaura coupling of heteroaryl halides - understanding the trends for pharmaceutically important classesJoshua Almond-Thynne, David C Blakemore, David C Pryde, et al.Bioorganic & Medicinal Chemistry Letters|September 24, 2008
Small, non-peptide C5a receptor antagonists: part 1Julian Blagg, Charles Mowbray, David C Pryde, et al.European Journal of Medicinal Chemistry|January 8, 2022
The discovery of potent small molecule cyclic urea activators of STINGSourav Basu, Sandip Middya, Monali Banerjee, et al.European Journal of Medicinal Chemistry|October 10, 2020
The discovery of potent small molecule activators of human STINGDavid C Pryde, Sandip Middya, Monali Banerjee, et al.European Journal of Medicinal Chemistry|April 3, 2025
Synthesis and structure-activity evaluation of a series of novel tricyclic STING activatorsSourav Basu, Sandip Middya, Ritesh Shrivastava, et al.Plos One|September 10, 2020
G10 is a direct activator of human STINGMonali Banerjee, Sandip Middya, Ritesh Shrivastava, et al.Bioorganic & Medicinal Chemistry Letters|September 20, 2016
Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1Aymeric Monteillier, Alexandre Loucif, Kiyoyuki Omoto, et al.Pageof 5